Jennifer R. Brown
Jennifer R. Brown, MD, PhD

Dana-Farber Cancer Institute

Inhye E. Ahn
Inhye E. Ahn, MD

National Cancer Institute

Accredited by

American Society of Clinical Oncology

Course Description

At the end of this course, learners should be able to:

- Evaluate relevant disease and patient factors to inform treatment choice for a patient with CLL.
- Appreciate unique considerations in the assessment of older patients with CLL.
- Evaluate the role of targeted agents and combined modality regimens in the treatment of relapsed CLL.
- Identify key side effects of targeted agents and apply appropriate supportive care measures.
- Compare efficacy and toxicity of chemoimmunotherapy vs. targeted agents in specific patient populations.

Activity Details

Credit Types:CME / MOC / CNE / CPE
Credit Amount:1.50 Credits
Expiration Date:2020-Sep-19
Registration Required:Yes

Suggest a CME Activity

Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.

OpenCME for Publishers

Please use the form below if you would like to offer your website visitors high-quality CME content by adding the OpenCME Widget to one or more of your pages.

Send Email to a Colleague

To share this activity with one or more colleagues, enter their e-mail addresses below. To include a personal message, simply overwrite the suggested text below.

(So your recipient knows it's from you.)
Enter multiple recipients separated by a space.
Optionally, replace/modify in the box above the message that will be sent to your colleague(s) with a link to download this app.